Friday, September 23, 2016 10:28:54 AM
PJET SEVERELY UNDERVALUED
PJET SUMMARY from FILINGS from the last 6 months:
http://www.otcmarkets.com/financialReportViewer?symbol=PJET&id=158477
Revenues = $2,820,029
Net Profit/Income = $1,481,065
Primary reason for one to invest/trade PJET. I believe the operational piece existing here with PJET easily warrants trading in a few pennies as explained below.
PJET having Net Income in the amount of $1,481,065 for the past six months ending within its financials is huge and makes PJET worth over .08+ per share as I will elaborate to justify such logic.
Although share count is much lower even using the Authorized Shares (AS) which can be confirmed below in the amount of 250,000,000 Shares as the OS to justify a fundamental valuation as a worst case scenario number for the OS:
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=vZb1UnVOqwgLTXHzDm991Q%253d%253d&nt7=0
The Earnings Per Share (EPS) for the six months ending was .01 per share within the PJET financials from them considering an OS of 127,000,000+ shares, but as I stated above, I would like to derive a ”worst case scenario” valuation by considering the OS being maxed out to be 250,000,000 Shares since that is the maxed amount for the Authorized Shares (AS). Consider the new EPS and valuation below:
$1,481,065 Net Income ÷ 250,000,000 OS = .0059 EPS
Now we must multiply the EPS by a Price to Earnings (P/E) ratio to determine the fundamental share price for where PJET could fundamentally exist. From the Yahoo Finance website below, I think it’s fair to see that PJET could very well exist within the Services Sector and further existing within the Regional Airlines Industry with 14.1 as its current P/E Ratio:
https://biz.yahoo.com/p/771conameu.html
This means the following valuation for PJET…
.0059 EPS x 14.10 P/E Ratio = .083 Per Share Valuation
This means that based on the 6 months ending financials for PJET, the company is worth .083 per share considering if the OS was maxed out to be 250,000,000 shares. I would suggest that all keep in mind that the last reported OS for PJET is much lower than that waiting for latest info from TA:
http://www.otcmarkets.com/stock/PJET/profile
Please understand about this valuation post. The validity of the valuation within this post transpiring will not be predicated upon me just saying so or believing that such could happen as a possibility. What I think and/or believe doesn’t matter. It matters what the market will eventually think. The validity of the valuation transpiring within this post will be predicated upon the market realizing and making such transpire.
Something else important to note, the valuation above was based on the six month ending financials. The three month ending financials reflected an EPS of (.00) per share which is really not bad considering its share structure, but it is not as good as its six months ending EPS. Considering the reasons for why such had transpired, I am confident that the six month numbers will begin to be more consistent for what PJET will continue to generate. With the company having $409,008 indicated as cash on hand within its Cash Flow Statement, confirms my beliefs of such being documented Expenses of which I believe the company will have no problem eliminating such Expenses to remain profitable going forward.
Also, this valuation does not include any potential contract that could be in the queue for PJET. Any announcement of any kind of substantial contract would significantly enhance the .08+ per share valuation stated above.
The growth is confirmed from its current operations below:
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM